RSS

Merck

Hard-to-reach locations could see temperature-controlled medicines and vaccines being delivered by drones thanks to a project led by humanitarian aid organisation Direct Relief. Read more

News

European Pharmaceutical Manufacturer editor Reece Armstrong finds out how a new packaging plan from Merck is challenging sustainability in pharma. Read more

Opinion

EPM editor Reece Armstrong sits down with Andrew Bulpin - head of process solutions at the life science business of Merck - to discuss the industry and the company’s new platform for ‘contiGuous’ manufacturing in bioprocessing. Read more

Opinion

A new agreement in the peptide therapeutics area between integrated drug discovery company, IRBM, and Merck (which is known as MSD outside the US and Canada) has been announced. Read more

News

After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. Read more

Analysis

A proof of concept field trial is being performed by AT&T and Softbox in collaboration with Merck to test the viability of using connected payloads and drones to deliver temperature-sensitive medicines. Read more

Technology

The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData Read more

Opinion

Science and technology company, Merck, has entered into a cooperation agreement with Netherlands-based InnoCore Pharmaceuticals, for a new drug delivery platform that will aim to improve patient compliance. Read more

News

A label change for MSD’s (known as Merck in the US and Canada) ulcerative colitis (UC) treatment — SIMPONI (golimumab) — has received approval from the European Commission. Read more

News

After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain Read more

Analysis

Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more

News

Science and technology company, Merck, has entered into an agreement with HistoCyte Laboratories, for the distribution of its portfolio of cell line reference products for immunohistochemistry and in situ hybridisation. Read more

News

Data has been presented by AstraZeneca and Merck demonstrating clinical improvement in median radiologic progression-free survival (rPFS) with Lynparza (olaparib) in combination with abiraterone compared to abiraterone monotherapy, a standard of care Read more

News

Science and technology company, Merck, has announced a collaboration with Swiss contract research and service provider, Solvias, for a new monocyte activation test (MAT) kit for pyrogen detection. Read more

Technology

The European Medicines Agency (EMA) has approved AstraZeneca and Merck’s Lynparza (olaparib) tablets as maintenance therapy for the treatment of platinum-sensitive relapsed ovarian cancer, regardless of BRCA status. Read more

News

With a spring in their step, manufacturing experts from pharma and biotech descend on New York to enjoy the offerings from this year’s Interphex meeting. Here’s our brief round-up of what to see from exhibitors at the event on day one… Read more

News

Science and technology company, Merck, has partnered with Oxford University’s Jenner Institute to develop cost-effective vaccine manufacturing processes, aimed at speeding up vaccine availability. Read more

News

Merck has revealed its collaboration with US-based Medisafe, which is aimed at helping cardiometabolic patients better manage medication intake and adherence to prescribed treatment regimens through a digital offering. Read more

News

Science and technology company, Merck, has been named as the overall ‘Best Bioprocessing Supplier’ at the Asia-Pacific Bioprocessing Excellence Awards where it also won the sub-category of ‘Best Bioprocessing Supplier Award for Single-use Systems’. Read more

News

The Scottish Medicines Consortium (SMC) has issued its final advice, recommending restricted use of cladribine tablets (Mavenclad, Merck) for the treatment of highly active relapsing multiple sclerosis (MS). Read more

News